TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member

TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine today announced the appointment of Felix Frueh PhD, as new member of the company’s Board of Directors. EN.

TcLand Expression SA, société leader dans le domaine des biomarqueurs d’expression de gènes en immunologie et médecine personnalisée annonce aujourd’hui la nomination du Dr. Felix Frueh, en tant que nouveau membre de son conseil d’administration. FR.

This entry was posted in Corporate. Bookmark the permalink.

Comments are closed.